Literature DB >> 8816134

Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group.

F Dromer1, S Mathoulin, B Dupont, A Laporte.   

Abstract

We analyzed the data collected during a nationwide survey of cryptococcosis (1985-1993). We first checked the quality of the survey. The stability of its completeness (approximately 50%) and its representativity were assessed by the capture-recapture method after we cross-checked our data on cryptococcosis (as a presenting manifestation of AIDS) against those of the national registry of AIDS. Of the 1,057 cases of cryptococcosis (1,013 patients), 827 (86%) involved patients with AIDS. The increasing number of cases of human immunodeficiency virus (HIV)-related cryptococcosis over time paralleled the AIDS epidemic except for a higher male-to-female ratio. Malignancies (32%), organ transplantation (19%), and corticosteroid therapy (33%) were the main predisposing conditions in 163 patients without AIDS. Cryptococcal meningitis more frequently occurred in patients with AIDS than in HIV-negative patients (P < 10(-6)). Among the 413 isolates available for serotyping, 410 were Cryptococcus neoformans variety neoformans (including 20.5% of serotype D). Three isolates of the variety gattii (serotype B) were recovered from patients without AIDS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816134     DOI: 10.1093/clinids/23.1.82

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  58 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation.

Authors:  A Guerrero; N Jain; X Wang; B C Fries
Journal:  Infect Immun       Date:  2010-01-04       Impact factor: 3.441

Review 3.  Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis.

Authors:  Gunjan Gupta; Bettina C Fries
Journal:  Future Microbiol       Date:  2010-05       Impact factor: 3.165

4.  Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.

Authors:  E Dannaoui; M Abdul; M Arpin; A Michel-Nguyen; M A Piens; A Favel; O Lortholary; F Dromer
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

5.  Genetic multilocus studies of different strains of Cryptococcus neoformans: taxonomy and genetic structure.

Authors:  S Bertout; F Renaud; D Swinne; M Mallié; J M Bastide
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.

Authors:  S P Franzot; I F Salkin; A Casadevall
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Molecular typing of IberoAmerican Cryptococcus neoformans isolates.

Authors:  Wieland Meyer; Alexandra Castañeda; Stuart Jackson; Matthew Huynh; Elizabeth Castañeda
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

8.  A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Authors:  Tran Th Chau; Nguyen H Mai; Nguyen H Phu; Ho D Nghia; Ly V Chuong; Dinh X Sinh; Van A Duong; Pham T Diep; James I Campbell; Stephen Baker; Tran T Hien; David G Lalloo; Jeremy J Farrar; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

9.  Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention.

Authors:  Akansha Jain; Shubham Jain; Swati Rawat
Journal:  J Pharm Bioallied Sci       Date:  2010-10

10.  Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.

Authors:  Eleni Galanis; Laura Macdougall; Sarah Kidd; Mohammad Morshed
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.